Updates to the ESMO CLL clinical practice guidelines: implications for frontline treatment Podcast Por arte de portada

Updates to the ESMO CLL clinical practice guidelines: implications for frontline treatment

Updates to the ESMO CLL clinical practice guidelines: implications for frontline treatment

Escúchala gratis

Ver detalles del espectáculo

Acerca de esta escucha

In this VJHemOnc podcast, experts Barbara Eichhorst, MD, University Hospital Cologne, Cologne, Germany, Lydia Scarfò, MD, Vita-Salute San Raffaele University and IRCCS San Raffaele Scientific Institute, Milan, Italy, and Anna Schuh, MD, PhD, University of Oxford, Oxford, UK, provide insights into the latest updates to the ESMO clinical practice guidelines for chronic lymphocytic leukemia (CLL). They cover key topics such as diagnostic advancements, frontline treatment strategies based on IGHV mutational status, the role of double oral combinations, the importance of measurable residual disease (MRD)-guided treatment, and the debate between time-limited and continuous regimens.
adbl_web_global_use_to_activate_T1_webcro805_stickypopup
Todavía no hay opiniones